A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Clinical trial NCT05487599 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05487599
Sponsor: Prevail Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease Gaucher Disease, Type 1

Start date: 2022-12-20
Primary completion: 2031-08-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.